Cite
HARVARD Citation
Xue, E. et al. (2021). Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience. Leukemia research. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xue, E. et al. (2021). Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience. Leukemia research. p. . [Online].